NSG 6005 TEST 8 NEWEST VERSION 2025/2026
COMPLETE 100 + BONUS OF MOST TESTED
QUESTIONS IN PREVIOUS YEARS QUESTIONS
AND CORRECT DETAILED ANSWERS WITH
RATIONALES (VERIFIED ANSWERS) |ALREADY
GRADED A+
The drugs recommended by the American Academy of Pediatrics for use
in children with diabetes (depending upon type of diabetes) are:
A. Metformin and insulin
B. Sulfonylureas and insulin glargine
C. Split-mixed dose insulin and GPL-1 agonists
D. Biguanides and insulin lispro - ANSWER-A. Metformin and insulin
Unlike most Type 2 diabetics where obesity is a major issue, older adults
with low body weight have higher risks for morbidity and mortality. The
most reliable indicator of poor nutritional status in older adults is:
A. Weight loss in previously overweight persons
B. Involuntary loss of 10% of body weight in less than 6 months
C. Decline in lean body mass over a 12-month period
,D. Increase in central versus peripheral body adiposity - ANSWER-B.
Involuntary loss of 10% of body weight in less than 6 months
The drugs recommended for older adults with Type 2 diabetes include:
A. Second generation sulfonylureas
B. Metformin
C. Pioglitazone
D. Third generation sulfonylureas - ANSWER-D. Third generation
sulfonylureas
Ethnic groups differ in their risk for and presentation of diabetes.
Hispanics:
A. Have a high incidence of obesity, elevated triglycerides, and
hypertension
B. Do best with drugs that foster weight loss, such as metformin
C. Both A and B
D. Neither A nor B - ANSWER-C. Both A and B
The American Heart Association states that people with diabetes have a
2- to 4-fold increase in the risk of dying from cardiovascular disease.
Treatments and targets that do not appear to decrease risk for micro-
and macro-vascular complications include:
,A. Glycemic targets between 7% and 7.5%
B. Use of insulin in Type 2 diabetics
C. Control of hypertension and hyperlipidemia
D. Stopping smoking - ANSWER-A. Glycemic targets between 7% and
7.5%
All diabetic patients with known cardiovascular disease should be
treated with:
A. Beta blockers to prevent MIs
B. ACE inhibitors and aspirin to reduce risk of cardiovascular events
C. Sulfonylureas to decrease cardiovascular mortality
D. Pioglitazone to decrease atherosclerotic plaque buildup - ANSWER-B.
ACE inhibitors and aspirin to reduce risk of cardiovascular events
All diabetic patients with hyperlipidemia should be treated with:
A. HMG-CoA reductase inhibitors
B. Fibric acid derivatives
C. Nicotinic acid
D. Colestipol - ANSWER-A. HMG-CoA reductase inhibitors
, All diabetic patients with hyperlipidemia should be treated with:
A. HMG-CoA reductase inhibitors
B. Fibric acid derivatives
C. Nicotinic acid
D. Colestipol - ANSWER-C. Nicotinic acid
Protein restriction helps slow the progression of albuminuria, GFR
decline, and ESRD is some patients with diabetes. It is useful for
patients who:
A. Cannot tolerate ACE inhibitors or ARBs
B. Have uncontrolled hypertension
C. Have HbA1C levels above 7%
D. Show progression of diabetic nephropathy despite optimal glucose
and blood pressure control - ANSWER-D. Show progression of
diabetic nephropathy despite optimal glucose and blood pressure
control
Diabetic autonomic neuropathy (DAN) is the earliest and most common
complication of diabetes. Symptoms associated with DAN include:
A. Resting tachycardia, exercise intolerance, and orthostatic
hypotension
COMPLETE 100 + BONUS OF MOST TESTED
QUESTIONS IN PREVIOUS YEARS QUESTIONS
AND CORRECT DETAILED ANSWERS WITH
RATIONALES (VERIFIED ANSWERS) |ALREADY
GRADED A+
The drugs recommended by the American Academy of Pediatrics for use
in children with diabetes (depending upon type of diabetes) are:
A. Metformin and insulin
B. Sulfonylureas and insulin glargine
C. Split-mixed dose insulin and GPL-1 agonists
D. Biguanides and insulin lispro - ANSWER-A. Metformin and insulin
Unlike most Type 2 diabetics where obesity is a major issue, older adults
with low body weight have higher risks for morbidity and mortality. The
most reliable indicator of poor nutritional status in older adults is:
A. Weight loss in previously overweight persons
B. Involuntary loss of 10% of body weight in less than 6 months
C. Decline in lean body mass over a 12-month period
,D. Increase in central versus peripheral body adiposity - ANSWER-B.
Involuntary loss of 10% of body weight in less than 6 months
The drugs recommended for older adults with Type 2 diabetes include:
A. Second generation sulfonylureas
B. Metformin
C. Pioglitazone
D. Third generation sulfonylureas - ANSWER-D. Third generation
sulfonylureas
Ethnic groups differ in their risk for and presentation of diabetes.
Hispanics:
A. Have a high incidence of obesity, elevated triglycerides, and
hypertension
B. Do best with drugs that foster weight loss, such as metformin
C. Both A and B
D. Neither A nor B - ANSWER-C. Both A and B
The American Heart Association states that people with diabetes have a
2- to 4-fold increase in the risk of dying from cardiovascular disease.
Treatments and targets that do not appear to decrease risk for micro-
and macro-vascular complications include:
,A. Glycemic targets between 7% and 7.5%
B. Use of insulin in Type 2 diabetics
C. Control of hypertension and hyperlipidemia
D. Stopping smoking - ANSWER-A. Glycemic targets between 7% and
7.5%
All diabetic patients with known cardiovascular disease should be
treated with:
A. Beta blockers to prevent MIs
B. ACE inhibitors and aspirin to reduce risk of cardiovascular events
C. Sulfonylureas to decrease cardiovascular mortality
D. Pioglitazone to decrease atherosclerotic plaque buildup - ANSWER-B.
ACE inhibitors and aspirin to reduce risk of cardiovascular events
All diabetic patients with hyperlipidemia should be treated with:
A. HMG-CoA reductase inhibitors
B. Fibric acid derivatives
C. Nicotinic acid
D. Colestipol - ANSWER-A. HMG-CoA reductase inhibitors
, All diabetic patients with hyperlipidemia should be treated with:
A. HMG-CoA reductase inhibitors
B. Fibric acid derivatives
C. Nicotinic acid
D. Colestipol - ANSWER-C. Nicotinic acid
Protein restriction helps slow the progression of albuminuria, GFR
decline, and ESRD is some patients with diabetes. It is useful for
patients who:
A. Cannot tolerate ACE inhibitors or ARBs
B. Have uncontrolled hypertension
C. Have HbA1C levels above 7%
D. Show progression of diabetic nephropathy despite optimal glucose
and blood pressure control - ANSWER-D. Show progression of
diabetic nephropathy despite optimal glucose and blood pressure
control
Diabetic autonomic neuropathy (DAN) is the earliest and most common
complication of diabetes. Symptoms associated with DAN include:
A. Resting tachycardia, exercise intolerance, and orthostatic
hypotension
